EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.

André Q C Miguel iD, Nicole Akana iD, Rachel Ryan iD, Alex Schmidt iD, Sean Hovland iD, Brian Stark iD, Sierra Colletto iD, Abigail Bowen iD, Nicole Rodin iD, Crystal L Smith iD, Sterling M McPherson iD

Experimental and Clinical Psychopharmacology · 2026

DOI: 10.1037/pha0000790 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Experimental and Clinical Psychopharmacology, 2026. Verfasst von André Q C Miguel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University. Hauptthemen laut MEDLINE: Varenicline, Smoking Cessation, Mobile Applications, Smoking Cessation Agents. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Washington State University Alcohol and Drug Abuse Research Program, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VareniclineSmoking CessationMobile ApplicationsSmoking Cessation AgentsAlcoholismHumansMaleFemalePilot ProjectsFeasibility StudiesAdultMiddle AgedTreatment OutcomeSmokers

Substanzen

VareniclineSmoking Cessation Agents

Autor:innen und Institutionen

  • Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University.
  • Department of Community and Behavioral Health, Analytics and PsychoPharmacology Laboratory, Washington State University.

ORCID-Profile: André Q C Miguel, Nicole Akana, Rachel Ryan, Alex Schmidt, Sean Hovland, Brian Stark, Sierra Colletto, Abigail Bowen, Nicole Rodin, Crystal L Smith, Sterling M McPherson

Förderung

  • NCI NIH HHS
  • Washington State University Alcohol and Drug Abuse Research Program
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Miguel, A. Q. C., Akana, N., Ryan, R., Schmidt, A., Hovland, S., Stark, B., Colletto, S., Bowen, A., Rodin, N., Smith, C. L., & McPherson, S. M. (2026). App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000790

Vancouver

Miguel AQC, Akana N, Ryan R, Schmidt A, Hovland S, Stark B, et al. App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial. Experimental and Clinical Psychopharmacology. 2026. doi:10.1037/pha0000790

BibTeX
@article{Miguel2026,
  author = {Miguel, André Q C and Akana, Nicole and Ryan, Rachel and Schmidt, Alex and Hovland, Sean and Stark, Brian and Colletto, Sierra and Bowen, Abigail and Rodin, Nicole and Smith, Crystal L and McPherson, Sterling M},
  title = {App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2026},
  doi = {10.1037/pha0000790}
}
Kostenlos starten →